Malignant fibrous histiocytoma of bone: Analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry

European Journal of Cancer

Volumn 42, Issue 8, 2006, Pages 1172-1180

  Tarkkanen, Maija ^a,b   Larramendy, Marcelo L ^a,c   Böhling, Tom ^a   Serra, Massimo ^d   Hattinger, Claudia M ^d   Kivioja, Aarne ^b   Elomaa, Inkeri ^b   Picci, Piero ^d   Knuutila, Sakari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

C MYC; Comparative genomic hybridisation; Comparative study; Histiocytoma; Human; Immunohistochemistry; Malignant fibrous histiocytoma of bone; Proto oncogene proteins c myc

Indexed keywords

DNA; MYC PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BONE TUMOR; CANCER GENETICS; CANCER INVASION; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 1Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DNA SEQUENCE; FEMALE; FIBROSARCOMA; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOSS; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; ONCOGENE C MYC; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SAMPLE; SCHOOL CHILD; SOFT TISSUE CANCER;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BONE NEOPLASMS; CHILD; CHROMOSOME ABERRATIONS; FEMALE; GENES, MYC; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-MYC; SOFT TISSUE NEOPLASMS;

EID: 33646520322     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.035     Document Type: Article

References (46)

1. Steiner G.C., Jundt G., and Martignetti J.A. Malignant fibrous histiocytoma of bone. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). Pathology and genetics of tumours of soft tissue and bone (2002), IARC Press, Lyon 294-296
2. Huvos A.G. Malignant fibrous histiocytoma. Bone tumours: diagnosis, treatment and prognosis. 2nd ed. (1991), WB Saunders, Philadelphia
3. Wold L.E., McLeod R.A., Sim F.H., and Unni K.K. Malignant fibrous histiocytoma. Atlas of orthopedic pathology (1990), WB Saunders, Philadelphia 136-141
4. Dunham W.K., and Wilborn W.H. Malignant fibrous histiocytoma of bone. Report of two cases and review of the literature. J Bone Joint Surg Am 61 (1979) 939-942
5. Bacci G., Picci P., Mercuri M., Bertoni F., and Ferrari S. Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone. Clin Orthop 346 (1998) 178-189
6. Bielack S.S., Schroeders A., Fuchs N., et al. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand 70 (1999) 353-360
7. Picci P., Bacci G., Ferrari S., and Mercuri M. Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors. Ann Oncol 8 (1997) 1107-1115
8. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations in Cancer, 2005. Available from: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
9. Bridge J.A., Sanger W.G., Neff J.R., and Hess M.M. Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology 22 (1990) 16-19
10. Mandahl N., Heim S., Arheden K., Rydholm A., Willén H., and Mitelman F. Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet 30 (1988) 23-33
11. Molenaar W.M., van den Berg E., Veth R.P.H., Dijkhuizen T., and de Vries E.G.E. Tumor progression in a giant cell type malignant fibrous histiocytoma of bone: clinical, radiologic, histologic, and cytogenetic evidence. Genes Chromosomes Cancer 10 (1994) 66-70
12. Walter T.A., Weh H.-J., Schlag P.M., Zornig C., and Hossfeld D.K. Cytogenetic studies in malignant fibrous histiocytoma. Cancer Genet Cytogenet 94 (1997) 131-134
13. Örndal C., Mandahl N., Carlén B., et al. Near-haploid clones in a malignant fibrous histiocytoma. Cancer Genet Cytogenet 60 (1992) 147-151
14. Ueda Y., Dockhorn-Dworniczak B., Blasius S., et al. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 119 (1993) 172-178
15. Araki N., Uchida A., Kimura T., et al. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop 270 (1991) 271-277
16. Naka T., Iwamoto Y., Shinohara N., Ushijima M., Chuman H., and Tsuneyoshi M. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pathol 10 (1997) 832-838
17. Mandahl N., Heim S., Willén H., et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer 1 (1989) 9-14
18. Szymanska J., Tarkkanen M., Wiklund T., et al. A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet 85 (1995) 91-96
19. Nilbert M., Rydholm A., Mitelman F., Meltzer P.S., and Mandahl N. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 83 (1995) 32-36
20. Larramendy M.L., Tarkkanen M., Blomqvist C., et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151 (1997) 1153-1161
21. Tarkkanen M., Elomaa I., Blomqvist C., et al. DNA sequence copy number increase at 8q - a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84 (1999) 114-121
22. Hattinger C.M., Tarkkanen M., Benini S., et al. Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol 83 (2004) 483-491
23. Heliö H., Kivioja A., Karaharju E.O., Elomaa I., and Knuutila S. Malignant fibrous histiocytoma arising in a previous site of fracture and osteomyelitis. Eur J Surg Oncol 19 (1993) 479-484
24. Larramendy M.L., Tarkkanen M., Valle J., et al. Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol 150 (1997) 685-691
25. Shen J., Scotlandi K., Baldini N., et al. Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities. Oncology 58 (2000) 253-260
26. Mairal A., Terrier P., Chibon F., Sastre X., Lecesne A., and Aurias A. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. Cancer Genet Cytogenet 111 (1999) 134-138
27. Simons A., Schepens M., Jeuken J., et al. Frequent loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 118 (2000) 89-98
28. Lau C.C., Harris C.P., Lu X.-Y., et al. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 39 (2004) 11-21
29. Stock C., Kager L., Fink F.-M., Gadner H., and Ambros P.F. Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer 28 (2000) 329-336
30. Gamberi G., Benassi M., Böhling T., et al. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 55 (1998) 556-563
31. Barrios C., Castresana J.S., Ruiz J., and Kreicbergs A. Amplification of the c-myc proto-oncogene in soft tissue sarcomas. Oncology 51 (1994) 13-17
32. Forozan F., Karhu R., Kononen J., Kallioniemi A., and Kallioniemi O.-P. Genomic screening by comparative genomic hybridization. Trends Genet 13 (1997) 405-409
33. Forus A., Weghuis D.O., Smeets D., Fodstad Ø., Myklebost O., and van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 14 (1995) 15-21
34. Tarkkanen M., Karhu R., Kallioniemi A., et al. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55 (1995) 1334-1338
35. Armengol G., Tarkkanen M., Virolainen M., et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridisation. Br J Cancer 75 (1997) 1403-1409
36. Forus A., Weghuis D.O., Smeets D., Fodstad Ø., Myklebost O., and van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14 (1995) 8-14
37. Szymanska J., Tarkkanen M., Wiklund T., et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 15 (1996) 89-94
38. Forus A., Berner J.-M., Meza-Zepeda L.A., et al. Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer 78 (1998) 495-503
39. Forus A., D'Angelo A., Henriksen J., et al. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity. Oncogene 20 (2001) 6881-6890
40. Knuutila S., Björkqvist A.-M., Autio K., et al. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol 152 (1998) 1107-1123
41. Ferracini R., Di Renzo M.F., Scotlandi K., et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10 (1995) 739-749
42. Fukuda T., Ichimura E., Shinozaki T., et al. Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors. Pathol Int 48 (1998) 757-762
43. Leach F.S., Tokino T., Meltzer P., et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53 (1993) 2231-2234
44. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., and Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (1992) 80-83
45. Martignetti J., Gelb B., Pierce H., Picci P., and Desnick R. Malignant fibrous histiocytoma: inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22 - evidence for a common genetic defect. Genes Chromosomes Cancer 27 (2000) 191-195
46. Tarkkanen M., Huuhtanen R., Virolainen M., et al. Comparison of genetic changes in primary sarcomas and their pulmonary metastases. Genes Chromosomes Cancer 25 (1999) 323-331